Literature DB >> 12862185

Health care resource use and stroke outcome. Multinational comparisons within the GAIN International trial.

Kjell Asplund1, Sharron Ashburner, Kathy Cargill, Margaret Hux, Ken Lees, Michael Drummond.   

Abstract

BACKGROUND AND
PURPOSE: Outcome in patients hospitalized for acute stroke varies considerably between populations. Within the framework of the GAIN International trial, a large multicenter trial of a neuroprotective agent (gavestinel, glycine antagonist), stroke outcome in relation to health care resource use has been compared in a large number of countries, allowing for differences in case mix.
METHODS: This substudy includes 1,422 patients in 19 countries grouped into 10 regions. Data on prognostic variables on admission to hospital, resource use, and outcome were analyzed by regression models.
RESULTS: All results were adjusted for differences in prognostic factors on admission (NIH Stroke Scale, age, comorbidity). There were threefold variations in the average number of days in hospital/institutional care (from 20 to 60 days). The proportion of patients who met with professional rehabilitation staff also varied greatly. Three-month case fatality ranged from 11% to 28%, and mean Barthel ADL score at three months varied between 64 and 73. There was no relationship between health care resource use and outcome in terms of survival and ADL function at three months. The proportion of patients living at home at three months did not show any relationship to ADL function across countries.
CONCLUSIONS: There are wide variations in health care resource use between countries, unexplained by differences in case mix. Across countries, there is no obvious relationship between resource use and clinical outcome after stroke. Differences in health care traditions (treatment pathways) and social context seem to be major determinants of resource use. In making comparisons between countries, great care should be exercised in using outcome variables as indicators of quality of stroke care.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12862185     DOI: 10.1017/s0266462303000242

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  5 in total

1.  Significant variation in mortality and functional outcome after acute ischaemic stroke between Western countries: data from the tinzaparin in acute ischaemic stroke trial (TAIST).

Authors:  L J Gray; N Sprigg; P M W Bath; P Sørensen; E Lindenstrøm; G Boysen; P P De Deyn; P Friis; D Leys; R Marttila; J-E Olsson; D O'Neill; B Ringelstein; J-J van der Sande; A G G Turpie
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-07-26       Impact factor: 10.154

2.  End of life after stroke: A nationwide study of 42,502 deaths occurring within a year after stroke.

Authors:  Kjell Asplund; Staffan Lundström; Birgitta Stegmayr
Journal:  Eur Stroke J       Date:  2017-10-06

3.  Disparities in postacute rehabilitation care for stroke: an analysis of the state inpatient databases.

Authors:  Janet K Freburger; George M Holmes; Li-Jung E Ku; Malcolm P Cutchin; Kendra Heatwole-Shank; Lloyd J Edwards
Journal:  Arch Phys Med Rehabil       Date:  2011-08       Impact factor: 3.966

4.  In patient stroke rehabilitation efficiency: influence of organization of service delivery and staff numbers.

Authors:  Jean Woo; Shiu Yu Chan; Mi Wan Cecilia Sum; Eric Wong; Yeuk Ping Maria Chui
Journal:  BMC Health Serv Res       Date:  2008-04-17       Impact factor: 2.655

5.  Can caregivers report their care recipients' post-stroke hospitalizations and outpatient visits accurately? Findings of an Asian prospective stroke cohort.

Authors:  Shilpa Tyagi; Gerald Choon-Huat Koh; Nan Luo; Kelvin Bryan Tan; Helen Hoenig; David B Matchar; Joanne Yoong; Eric A Finkelstein; Kim En Lee; N Venketasubramanian; Edward Menon; Kin Ming Chan; Deidre Anne De Silva; Philip Yap; Boon Yeow Tan; Effie Chew; Sherry H Young; Yee Sien Ng; Tian Ming Tu; Yan Hoon Ang; Keng He Kong; Rajinder Singh; Reshma A Merchant; Hui Meng Chang; Tseng Tsai Yeo; Chou Ning; Angela Cheong; Yu Li Ng; Chuen Seng Tan
Journal:  BMC Health Serv Res       Date:  2018-10-25       Impact factor: 2.655

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.